glp-1 for menopause Agonists in Perimenopause: Unique Risks and Potential Opportunities GLP-1 Weight-Loss Drugs and Menopause:

Szczesnowicz, A., Szeliga, A., Niwczyk, O., Bala, G., & Meczekalski, B

Practically speaking, dulaglutide is rarely chosen as a primary weight loss alternative to tirzepatide

For patients with heart failure or chronic kidney disease, initiating an SGLT-2 inhibitor first is preferred

Numerous studies have found that GLP-1 agonists can be effective for weight loss, blood sugar management, and heart health, especially when combined with diet and lifestyle changes

These are the main elements that affect your GLP-1 average weight loss per month: 1

Provider-led, personalized approach Clinicians create a personalized treatment plan based on your goals, needs, and medical history